Viatris, Pacira cleared HSR waiting period on Oct. 29
MLex Summary: The required waiting period under the Hart-Scott-Rodino Act related to Viatris' acquisition of Pacira BioSciences expired just before midnight on Oct. 29. The deal is valued at $1.65 billion.Excerpt. ...To view the full article, register now.
Already a subscriber? Click here to view full article